NCT01696500View on ClinicalTrials.gov

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Stevens-Johnson SyndromeToxic Epidermal Necrolysis
Interventions
DRUG

Intravenous immunoglobulin

Trial Locations (1)

101-0031

Nihon Pharmaceutical Co., Ltd, Tokyo

Sponsors
All Listed Sponsors
lead

Nihon Pharmaceutical Co., Ltd

INDUSTRY